Lexeo Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -546 | -538 | -530 | -510 |
EBITDA | -19,633 | -20,356 | -19,671 | -25,534 |
EBIT | -20,179 | -20,894 | -20,201 | -26,044 |
Net Income | -20,196 | -20,919 | -20,283 | -26,103 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -21,179 | -20,079 | -29,836 | -27,327 |
Cash | 71,768 | 63,000 | 40,996 | 35,480 |
Basic Shares | 81,183 | 76,356 | 60,980 | 43,573 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $654 |
Gross Profit | -2,079 | -2,001 | -1,843 | 654 |
EBITDA | -97,676 | -96,194 | -64,346 | -58,041 |
EBIT | -99,755 | -98,196 | -66,189 | -59,186 |
Net Income | -99,961 | -98,333 | -66,394 | -59,277 |
Net Change In Cash | 0 | 0 | 0 | 654 |
Free Cash Flow | -98,958 | -81,632 | -59,661 | -55,461 |
Cash | 63,000 | 35,014 | 121,466 | 77,335 |
Basic Shares | 53,645 | 31,787 | 26,646 | 25,169 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.25 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.60 |